{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:07:46Z","timestamp":1788908866233,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","ejradiology.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejrad.2024.111711","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T20:43:07Z","timestamp":1725050587000},"page":"111711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer"],"prefix":"10.1016","volume":"180","author":[{"given":"Divya","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina P.","family":"Dutruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"O\u2019Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Ricaurte-Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rituraj","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Pannullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.S.","family":"Knisely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Brandmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6470-5400","authenticated-orcid":false,"given":"Jana","family":"Ivanidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2024.111711_b0005","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.3390\/diagnostics12112594","article-title":"PSMA PET-CT in the diagnosis and staging of prostate cancer","volume":"12","author":"Combes","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejrad.2024.111711_b0010","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S1470-2045(19)30415-2","article-title":"18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial","volume":"20","author":"Calais","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2024.111711_b0015","doi-asserted-by":"crossref","first-page":"e210091","DOI":"10.1148\/rycan.210091","article-title":"18F-fluciclovine versus PSMA PET imaging in primary tumor detection during initial staging of high-risk prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Yadav","year":"2022","journal-title":"Radiol. Imaging Cancer"},{"key":"10.1016\/j.ejrad.2024.111711_b0020","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4081\/aiua.2022.3.274","article-title":"Targeted prostate biopsy: 68Ga-PSMA PET\/CT vs. mpMRI in the diagnosis of prostate cancer","volume":"94","author":"Pepe","year":"2022","journal-title":"Arch. Ital. Urol. Androl. Organo Uff. Soc. Ital. Ecogr. Urol. E Nefrol."},{"key":"10.1016\/j.ejrad.2024.111711_b0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1470-2045(18)30198-0","article-title":"[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study","volume":"19","author":"Hofman","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2024.111711_b0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1470-2045(23)00529-6","article-title":"Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial","volume":"25","author":"Hofman","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2024.111711_b0035","article-title":"Ductal prostate cancer staging: role of PSMA PET\/CT","volume":"96","author":"Pepe","year":"2024","journal-title":"Arch. Ital. Urol. E Androl."},{"key":"10.1016\/j.ejrad.2024.111711_b0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1552-6569.2012.00767.x","article-title":"Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis","volume":"24","author":"Hatzoglou","year":"2014","journal-title":"J. Neuroimaging off. J. Am. Soc. Neuroimaging"},{"key":"10.1016\/j.ejrad.2024.111711_b0045","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1016\/j.wneu.2019.10.125","article-title":"Intracranial metastases from prostate carcinoma: classification, management, and prognostication","volume":"134","author":"Ganau","year":"2020","journal-title":"World Neurosurg."},{"key":"10.1016\/j.ejrad.2024.111711_b0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.clgc.2020.07.012","article-title":"Prostate cancer central nervous system metastasis in a contemporary cohort","volume":"19","author":"Boxley","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.ejrad.2024.111711_b0055","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.3390\/jcm11144165","article-title":"Prostate cancer brain metastasis: review of a rare complication with limited treatment options and poor prognosis","volume":"11","author":"Rajeswaran","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejrad.2024.111711_b0060","article-title":"Incidence of dural metastases in castrate-resistant prostate cancer","author":"Khondker","year":"2022","journal-title":"J. Clin. Urol."},{"key":"10.1016\/j.ejrad.2024.111711_b0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-004-8098-1","article-title":"Dural metastases","volume":"75","author":"Laigle-Donadey","year":"2005","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejrad.2024.111711_b0070","article-title":"PET\/MR imaging of somatostatin receptor expression and tumor vascularity in meningioma: implications for pathophysiology and tumor outcomes","volume":"11","author":"Roytman","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2024.111711_b0075","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jon.12632","article-title":"Gallium-68 DOTATATE PET in the evaluation of intracranial meningiomas","volume":"29","author":"Ivanidze","year":"2019","journal-title":"J. Neuroimaging off. J. Am. Soc. Neuroimaging"},{"key":"10.1016\/j.ejrad.2024.111711_b0080","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/neuonc\/nox112","article-title":"PET imaging in patients with meningioma-report of the RANO\/PET Group","volume":"19","author":"Galldiks","year":"2017","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.ejrad.2024.111711_b0085","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11060-023-04355-x","article-title":"Identification of incidental brain tumors in prostate cancer patients via PSMA PET\/CT","volume":"163","author":"McLaughlin","year":"2023","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejrad.2024.111711_b0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa","year":"2020","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ejrad.2024.111711_b0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1748-717X-5-46","article-title":"Assessment of epidermal growth factor receptor (EGFR) expression in human meningioma","volume":"5","author":"Wernicke","year":"2010","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ejrad.2024.111711_b0100","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"proPSMA study group collaborators, prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet. Lond. Engl."},{"key":"10.1016\/j.ejrad.2024.111711_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2024.109458","article-title":"Advanced prostate cancer with brain metastasis presenting with isolated severe headache without urinary symptoms: case report and literature review","volume":"117","author":"Nhungo","year":"2024","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.ejrad.2024.111711_b0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.soc.2023.02.007","article-title":"Advances in radiotherapy for brain metastases","volume":"32","author":"Matsui","year":"2023","journal-title":"Surg. Oncol. Clin. n. Am."},{"key":"10.1016\/j.ejrad.2024.111711_b0115","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.18632\/oncotarget.12240","article-title":"Preliminary experience with dosimetry, response and patient reported outcome after 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer","volume":"8","author":"Fendler","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejrad.2024.111711_b0120","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/RLU.0000000000001763","article-title":"Combination of 177Lu-PSMA-617 and external radiotherapy for the treatment of cerebral metastases in patients with castration-resistant metastatic prostate cancer","volume":"42","author":"Wei","year":"2017","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ejrad.2024.111711_b0125","doi-asserted-by":"crossref","first-page":"umae008","DOI":"10.1093\/radadv\/umae008","article-title":"Pathologic outcome of incidentally detected tracer-avid lesions in 68Ga-PSMA-11 PET\/CT for prostate cancer","volume":"1","author":"Mar","year":"2024","journal-title":"Radiol. Adv."},{"key":"10.1016\/j.ejrad.2024.111711_b0130","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/RLU.0000000000001451","article-title":"Diagnostic value of 68Ga PSMA-11 PET\/CT imaging of brain tumors-preliminary analysis","volume":"42","author":"Sasikumar","year":"2017","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ejrad.2024.111711_b0135","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.5858\/arpa.2010-0740-OA","article-title":"Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme","volume":"135","author":"Wernicke","year":"2011","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ejrad.2024.111711_b0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2867-14-26","article-title":"Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases","volume":"14","author":"Nomura","year":"2014","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejrad.2024.111711_b0145","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.3390\/cancers14164039","article-title":"PSMA radioligand uptake as a biomarker of neoangiogenesis in solid tumours: diagnostic or theragnostic factor?","volume":"14","author":"Rizzo","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2024.111711_b0150","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/jnen\/nlac089","article-title":"Prostate-specific membrane antigen expression in meningioma: a promising theranostic target","volume":"81","author":"Tubre","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejrad.2024.111711_b0155","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1097\/RLU.0000000000003629","article-title":"Distinguishing meningioma from metastasis of prostate cancer on 68Ga-PSMA PET\/CT","volume":"46","author":"Filizoglu","year":"2021","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ejrad.2024.111711_b0160","doi-asserted-by":"crossref","unstructured":"M.S. Hofman, R.J. Hicks, T. Maurer, M. Eiber, Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls, Radiogr. Rev. Publ. Radiol. Soc. N. Am. Inc 38 (2018) 200\u2013217. 10.1148\/rg.2018170108.","DOI":"10.1148\/rg.2018170108"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X24004273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X24004273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T10:24:43Z","timestamp":1725791083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X24004273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"alternative-id":["S0720048X24004273"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2024.111711","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2024.111711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111711"}}